Cubist Systematic Strategies LLC Purchases Shares of 8,774 Integer Holdings Corporation $ITGR

Key Points

• Cubist Systematic Strategies LLC purchased 8,774 shares of Integer Holdings Corporation valued at approximately $1,035,000 in Q1.
• A majority of the stock, 99.29%, is owned by institutional investors, with several firms increasing their positions in Integer.
• The company's most recent earnings report indicated a miss on EPS estimates, but revenue saw an 11.4% year-over-year increase.

Cubist Systematic Strategies LLC acquired a new position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,774 shares of the medical equipment provider's stock, valued at approximately $1,035,000.

Several other institutional investors have also recently bought and sold shares of the business. Paradigm Capital Management Inc. NY raised its holdings in shares of Integer by 426.2% in the first quarter. Paradigm Capital Management Inc. NY now owns 22,100 shares of the medical equipment provider's stock valued at $2,608,000 after purchasing an additional 17,900 shares during the last quarter. DRW Securities LLC purchased a new stake in shares of Integer in the first quarter valued at about $220,000. The Manufacturers Life Insurance Company raised its holdings in shares of Integer by 40.2% in the first quarter. The Manufacturers Life Insurance Company now owns 213,741 shares of the medical equipment provider's stock valued at $25,224,000 after purchasing an additional 61,273 shares during the last quarter. Magnetar Financial LLC purchased a new stake in shares of Integer in the first quarter valued at about $680,000. Finally, Axiom Investors LLC DE bought a new position in Integer during the first quarter valued at about $4,457,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Down 2.6%

Shares of NYSE:ITGR traded down $2.70 during trading on Friday, reaching $101.53. The stock had a trading volume of 236,393 shares, compared to its average volume of 464,818. Integer Holdings Corporation has a one year low of $101.16 and a one year high of $146.36. The company has a market capitalization of $3.56 billion, a P/E ratio of 44.73, a PEG ratio of 0.81 and a beta of 1.03. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. The firm's 50-day simple moving average is $109.92 and its 200 day simple moving average is $116.14.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm had revenue of $476.00 million during the quarter, compared to the consensus estimate of $464.37 million. During the same quarter in the prior year, the business posted $1.30 earnings per share. The firm's quarterly revenue was up 11.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, research analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Raymond James Financial dropped their price target on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research note on Friday, July 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and raised their target price for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Wells Fargo & Company lowered their target price on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Truist Financial lowered their target price on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday, July 25th. Finally, Wall Street Zen raised shares of Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Integer has an average rating of "Buy" and an average price target of $140.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.